Saliva Molecular Markers Offer Non-Invasive Prediction of Cancer, Heart Disease, and Parkinson's Risk

New research reveals saliva contains genetic markers that could predict the risk of developing cancer, heart disease, and Parkinson's through non-invasive testing, advancing early diagnosis and personalized medicine.
Researchers from the University of the Basque Country have uncovered a groundbreaking use of saliva as a diagnostic tool for systemic diseases. By analyzing saliva samples from over 350 individuals, the team identified hundreds of molecular markers—specifically genetic polymorphisms (SNPs)—that can signal an increased risk of developing major health conditions such as cancer, cardiovascular diseases, diabetes, and neurodegenerative disorders like Parkinson’s. Their findings, published in npj Genomic Medicine, demonstrate that saliva, a readily accessible biological fluid, harbors genetic information capable of reflecting systemic health states.
The study highlights that these genetic polymorphisms act as biological switches, turning specific genes on or off, which influences disease susceptibility. When comparing their data with global genetic studies, the scientists observed that many of these saliva-based markers are associated with higher risks for common diseases such as prostate cancer, coronary artery disease, Parkinson's, and Type 2 diabetes. Notably, using advanced statistical models, the researchers showed that these markers can explain a significant portion of the genetic heritability of these conditions, often with greater accuracy than traditional blood-based indicators.
Professor José Ramón Bilbao emphasized the underutilized potential of saliva in clinical practice, noting that saliva is one of the most accessible biological fluids. This research paves the way for the development of non-invasive, saliva-based diagnostic tests for early disease detection and ongoing health monitoring, eliminating the need for invasive procedures like blood draws. Another major contribution is the creation of an extensive, open-access database of genetic saliva data, intended to foster further research and innovation across biomedical fields.
While further validation in larger populations is necessary, this pioneering work suggests a future where early detection and personalized medicine could be significantly transformed using saliva as a diagnostic medium, making health assessments more accessible and less invasive. The findings underscore the incredible diagnostic potential hidden in everyday biological samples, opening new avenues for preventive healthcare.
Source: https://medicalxpress.com/news/2025-06-saliva-analysis-reveal-cancer-heart.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Study Reveals Patient Skepticism Toward Doctors Using Artificial Intelligence
A new study reveals that patients are more skeptical of doctors who use artificial intelligence, perceiving them as less competent and trustworthy, which may impact healthcare relationships.
Novo Nordisk Collaborates with US Biotech Firm to Develop Innovative Obesity Medications
Novo Nordisk and Septerna have embarked on a groundbreaking partnership to develop oral medications targeting GPCRs for obesity and metabolic diseases, promising more convenient treatment options.
Scientific Study Clears Mosquitoes of Role in Spreading Lyme Disease
New research confirms that mosquitoes do not transmit Lyme disease, with ticks remaining the primary vectors. This discovery refines our understanding of disease transmission and guides better prevention strategies.
Innovative Electrical Stimulation Technique Predicts Nerve Injury Recovery Outcomes
A groundbreaking study reveals how intraoperative electrical nerve stimulation can predict recovery potential after acute nerve injuries, aiding in personalized surgical decisions.



